What is the role of LMWH in the treatment of antithrombin III (ATIII) deficiency?

Updated: Mar 04, 2020
  • Author: James L Harper, MD; Chief Editor: Hassan M Yaish, MD  more...
  • Print

LMWH has been used to treat patients with heterozygotic gene mutations; however, as LMWH depends on antithrombin III for activity, anti-Xa activity levels should be closely monitored and doses should be adjusted to maintain anti-Xa activity levels in the 0.5-1 international units/mL.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!